Gene · 6528
Papers4,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer. | Front Oncol | 2025 | 40933893 | PubTator, text mining | PubMed |
| High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma. | Front Oncol | 2025 | 40927522 | PubTator, text mining | PubMed |
| Correction to "Identification and Characterization of the Biosynthesis of the Hybrid NRPS-NIS Siderophore Nocardichelin". | ACS Chem Biol | 2025 | 40893103 | PubTator, text mining | PubMed |
| Efficacy of Lenvatinib Therapy for Thyroid Cancer by Pathological Type: A Retrospective Real-world Study. | In Vivo | 2025 | 40877150 | PubTator, text mining | PubMed |
| Analysis of anti-cancer treatment therapies based on TOPSIS method under fractional Diophantine fuzzy Muirhead mean operators. | Sci Rep | 2025 | 40866354 | PubTator, text mining | PubMed |
| Abstracts from the 73rd Annual Meeting of the British Thyroid Association. | Thyroid Res | 2025 | 40855316 | PubTator, text mining | PubMed |
| Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer. | Proteomes | 2025 | 40843709 | PubTator, text mining | PubMed |
| Development and validation of a nomogram to predict failure of initial radioactive iodine therapy in differentiated thyroid cancer: a retrospective cohort study. | Sci Rep | 2025 | 40841440 | PubTator, text mining | PubMed |
| Identifying risk factors associated with refractoriness to radioiodine therapy in differentiated thyroid cancer. | Arch Endocrinol Metab | 2025 | 40834361 | PubTator, text mining | PubMed |
| Effects of Oxygen Manipulation on Myofibroblast Phenotypic Transformation in Patients With Radiation-Induced Fibrosis. | Wound Repair Regen | 2025 | 40824267 | PubTator, text mining | PubMed |
| A bibliometric analysis of inflammation and thyroid carcinoma: research trends and future perspectives. | Front Oncol | 2025 | 40823082 | PubTator, text mining | PubMed |
| Epigenetic control in thyroid cancer: mechanisms and clinical perspective. | Cell Death Discov | 2025 | 40819127 | PubTator, text mining | PubMed |
| Patient characteristics and adverse effects of allogeneic blood transfusion following lower extremity joint replacement in rheumatoid arthritis: a nationwide inpatient sample database study. | BMC Rheumatol | 2025 | 40804428 | PubTator, text mining | PubMed |
| A concise synthesis of pyrrolo[2,3-d]pyrimidine through I2/DMSO promoted cascade annulation. | BMC Chem | 2025 | 40804392 | PubTator, text mining | PubMed |
| Editorial: Microbiota homeostasis and metabolic reprogramming in cancer development and digestive diseases. | Front Cell Dev Biol | 2025 | 40766779 | PubTator, text mining | PubMed |
| The Minha Casa Minha Vida social housing programme and leprosy in Brazil: an analysis of the 100 Million Brazilian Cohort (2010-2015). | BMC Public Health | 2025 | 40759946 | PubTator, text mining | PubMed |
| The states of senescent cells. | Biochem Soc Trans | 2025 | 40758278 | PubTator, text mining | PubMed |
| Radical cascade cyclization of amino acid-tethered 1,6-enynones with sulfonyl hydrazides for N-terminal modification: synthesis of functionalized succinimide derivatives. | RSC Adv | 2025 | 40756662 | PubTator, text mining | PubMed |
| Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer. | Endocr Relat Cancer | 2025 | 40748136 | PubTator, text mining | PubMed |
| Gene Expression Analysis of Papillary Thyroid Carcinoma With Lymph Node Metastasis and Radioiodine Refractivity. | Cureus | 2025 | 40746809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6528/papers?page=8